Profile
Mark Mannebach worked at Santen, Inc. as VP-Global Regulatory Affairs from 2004 to 2008.
From 2008 to 2017, worked at Mallinckrodt Pharmaceuticals as VP-Global Regulatory Affairs.
Also worked at Harrow, Inc. as Head-Regulatory Affairs & Pharmacovigilance.
Held the position of Vice President-Regulatory Affairs at Celcuity, Inc. and Exicure, Inc. Served as Vice President-Global Regulatory Affairs at Eiger BioPharmaceuticals, Inc. Education includes undergraduate studies at Wayne State University (Michigan), graduate studies at the University of Detroit Mercy, and a doctorate from the University of Michigan.
Former positions of Mark Mannebach
| Companies | Position | End |
|---|---|---|
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | General Counsel | 2008-10-31 |
| CELCUITY INC. | General Counsel | - |
| HARROW, INC. | General Counsel | - |
| EXICURE, INC. | General Counsel | - |
Training of Mark Mannebach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Wayne State University (Michigan)
Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Detroit Mercy
University of Detroit Mercy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Health Technology |
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Celcuity, Inc.
Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Exicure, Inc.
Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
- Stock Market
- Insiders
- Mark Mannebach
















